Arachidonic Acid Metabolites in Neurologic Disorders

被引:27
作者
Kursun, Oguzhan [1 ]
Karatas, Hulya [2 ]
Bariskaner, Hulagu [3 ]
Ozturk, Serefnur [4 ]
机构
[1] Ankara City Hosp, Dept Neurol Clin, Neurointens Care Unit, Ankara, Turkey
[2] Hacettepe Univ, Inst Neurol Sci & Psychiat, Ankara, Turkey
[3] Selcuk Univ, Dept Pharmacol, Fac Med, Konya, Turkey
[4] Selcuk Univ, Fac Med, Dept Neurol, Konya, Turkey
关键词
Arachidonic acid; COX; LOX; stroke; neurodegenerative diseases; PGs; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; MOUSE MODEL; DOCOSAHEXAENOIC ACID; LIPID MEDIATORS; PROTEIN-KINASE; NEURODEGENERATIVE DISEASES; THERAPEUTIC STRATEGY; INTERNATIONAL UNION; PHOSPHOLIPASE A(2);
D O I
10.2174/1871527320666210512013648
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background and Objective: Arachidonic acid (ARA) is essential for the fluidity, selective permeability, and flexibility of the cell membrane. It is an important factor for the function of all cells, particularly in the nervous system, immune system, and vascular endothelium. ARA is the second most common polyunsaturated fatty acid in the phospholipids of the nerve cell membrane after docosahexaenoic acid. ARA metabolites have many kinds of physiologic roles. The major action of ARA metabolites is the promotion of the acute inflammatory response, mediated by the production of pro-inflammatory mediators such as PGE2 and PGI2, followed by the formation of lipid mediators, which have pro-resolving effects. Another important action of ARA derivatives, especially COX, is the regulation of vascular reactivity through PGs and TXA2. There is significant involvement of ARA metabolites in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropsychiatric disorders. ARA derivatives also make an important contribution to acute stroke, global ischemia, subarachnoid hemorrhage, and anticoagulation-related hemorrhagic transformation. Conclusion: In this review, we have discussed experimental and human study results of neurologic disorders related to ARA and its metabolites in line with treatment options.
引用
收藏
页码:150 / 159
页数:10
相关论文
共 101 条
[1]   Facilitation by arachidonic acid of acetylcholine release from the rat hippocampus [J].
Almeida, T ;
Cunha, RA ;
Ribeiro, JA .
BRAIN RESEARCH, 1999, 826 (01) :104-111
[3]   Polyunsaturated fatty acids and their metabolites in brain function and disease [J].
Bazinet, Richard P. ;
Laye, Sophie .
NATURE REVIEWS NEUROSCIENCE, 2014, 15 (12) :771-785
[4]   P-450 epoxygenase and NO synthase inhibitors reduce cerebral blood flow response to N-methyl-D-aspartate [J].
Bhardwaj, A ;
Northington, FJ ;
Carhuapoma, JR ;
Falck, JR ;
Harder, DR ;
Traystman, RJ ;
Koehler, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (04) :H1616-H1624
[5]   Regulated phosphorylation and dephosphorylation of tau protein: Effects on microtubule interaction, intracellular trafficking and neurodegeneration [J].
Billingsley, ML ;
Kincaid, RL .
BIOCHEMICAL JOURNAL, 1997, 323 :577-591
[6]   Arachidonic acid as a bioactive molecule [J].
Brash, AR .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (11) :1339-1345
[7]   The influence of dietary docosahexaenoic acid and arachidonic acid on central nervous system polyunsaturated fatty acid composition [J].
Brenna, J. Thomas ;
Diau, Guan-Yeu .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2007, 77 (5-6) :247-250
[8]   International union of pharmacology - XXXVII. Nomenclature for leukotriene and lipoxin receptors [J].
Brink, C ;
Dahlen, SE ;
Drazen, J ;
Evans, JF ;
Hay, DWP ;
Nicosia, S ;
Serhan, CN ;
Shimizu, T ;
Yokomizo, T .
PHARMACOLOGICAL REVIEWS, 2003, 55 (01) :195-227
[9]   12/15 lipoxygenase inhibition suppresses neuroinflammation in a thrombotic permanent cerebral ischemia model [J].
Cakir-Aktas, C. ;
Yemisci, M. ;
Bodur, E. ;
Eren-Kocak, E. ;
van Leyen, K. ;
Dalkara, T. ;
Kursun, H. Karatas .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 :863-864
[10]   Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage [J].
Cambj-Sapunar, L ;
Yu, M ;
Harder, DR ;
Roman, RJ .
STROKE, 2003, 34 (05) :1269-1275